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Background: Hirayama’s disease (HD), is a benign, self-limited, motor neuron disease, characterized by 
asymmetric weakness and atrophy of one or both distal upper extremities. In the present study we report the 
clinical, electrophysiological and MRI features of a group of Italian patients, with review of the literature. 
Moreover we propose an optimized MRI protocol for patients with suspected or diagnosed HD in order to 
make an early diagnosis and a standardized follow up. 
Methods: Eight patients with clinical suspicion of Hirayama disease underwent evaluation between 
January 2007 and November 2013. All patients underwent standard nerve conduction studies (NCS), 
electromyography (EMG) and motor/sensory evoked potentials (MEP/SEP). Cervical spine MRI studies 
were conducted with a 1.5 Tesla MRI scanner in neutral and flexion position, including sagittal T1-weighted 
sequences and sagittal and axial T2-weighted sequences. The following diagnostic features were evaluated: 
abnormal cervical curvature, localized cervical cord atrophy in the lower tract (C4–C7), presence of cord 
flattening (CF), intramedullary signal hyperintensity on T2 weighted sequences, anterior shifting of the 
posterior wall of the cervical dural sac (ASD) and presence of flow voids (EFV) in the posterior epidural 
space during flexion.
Results: All patients complained of weakness in hand muscles as initial symptoms, associated with hand 
tremor in three of them and abnormal sweating of the hand palm in two of them. No sensory deficits and 
weakness at lower limbs were reported by any patients. Distal deep tendon reflexes at upper limbs were 
absent in all patients with the absence of the right tricipital reflex in one of them. Deep tendon reflexes at 
lower limbs were normal and no signs of pyramidal tract involvement were present. The clinical involvement 
at onset was unilateral in six patients (three left-sided and three right-sided) and bilateral asymmetric in 
two of them, with the right side more affected. With the progression of the disease all patients but one 
experienced weakness and wasting of hand muscles and forearm bilaterally, but still asymmetric. The 
duration of the progression phase of the disease ranged from eight months to three years. In all patients, 
NCS and EMG findings were consistent with a spinal metameric disorder involving the C7-T1 myotomes 
bilaterally; sensory conduction and electrophysiologic features at lower limbs were normal. MEP and SEP 
were normal and we did not observe the disappearance of the spinal potential during the neck flexion in any 
of the patients. MRI is the best diagnostic tool in the diagnosis of HD; it can confirm clinical diagnosis and 
exclude other conditions responsible for the neurological deficits leading to a correct patient management 
and therapy, limiting arm impairment. On MRI all patients had loss of the normal cervical lordosis (100%). 
Five patients had loss of attachment of posterior dural sac and anterior dural shift on flexion MRI with 
presence of flow voids from venous plexus congestion (62.5%); three patients had no anterior dislocation 
of the dural sac and no epidural vein congestion. Two patients showed localized cord atrophy, one at C5–
C6 and the other at C6–C7 level (25%). Three patients had T2 intramedullary hyperintensities (37.5%) and 
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Introduction
Hirayama’s disease (HD), also known as “juvenile muscular 
atrophy of distal upper extremity” (JMADUE), was first 
described by Hirayama et al. in 1959 (1). Since then, the 
greatest number of cases have been reported from Japan and 
other Asian countries (1-6); in contrast, it is less common 
among the population of the North America and Europe, 
however lately some case series were published (7-10). 
Some case reports were reported in Italy (11-13) but to our 
knowledge this is the first reported Italian group of patients 
with HD.
The disease affects young people, predominantly men, in 
the second to third decades of life and it is characterized by 
an insidious onset, unilateral or bilateral asymmetric (rarely 
bilateral symmetric) weakness and atrophy of the forearm 
and hand with sparing of the brachioradialis muscle giving 
the characteristic appearance of oblique amyotrophy (14). 
HD is a benign, self-limiting pathology; after a 
progressive phase of the neurological deficits affecting the 
C7, C8 and T1 myotomes for about 1–5 years, it has a 
spontaneous arrest (15). The first autopsy obtained in 1982 
from a patient died of lung carcinoma, revealed antero-
posterior flattening and ischemic changes in the anterior 
horn cells of the lower cervical cord segment (16). 
HD is thought to be a flexion myelopathy related to 
forward displacement of the posterior wall of the lower 
cervical dural canal with neck flexion, but this theory is 
strongly debated (12,17). HD is predominantly sporadic 
and familial occurrence is very rare, but documented (1,17). 
Magnetic resonance imaging (MRI) features have been 
described in literature to aid the diagnosis of HD. In the 
present study we report our experience of HD and review 
the clinical, electrophysiological and MRI features, in 
both neutral and neck flexed position, of a group of Italian 
patients. Finally we propose an optimized MRI protocol for 
patients with suspected or diagnosed HD in order to make 
an early diagnosis and a standardized follow up. 
Methods
Eight patients (6 males, 2 females; age range 15–23 years) 
with clinical suspicion of Hirayama disease underwent 
clinical, electrophysiological and MRI diagnostic evaluation 
between January 2007 and November 2013 at University 
Hospital Federico II, Naples, Italy. We obtained written 
informed consent from all of our patients.
Diagnostic inclusion criteria for HD were (18,19): 
(I) weakness and atrophy of the upper limbs interesting 
predominantly forearms and hands; (II) unilateral or 
bilateral asymmetric signs and symptoms; (III) insidious 
onset in the teens or early 20’s; (IV) absence of substantial 
sensory and reflexes abnormalities of pyramidal tracts, lower 
limbs, cranial nerves, sphinterial or cerebellar deficits; (V) 
progression for few years followed by arrest of the disease; 
(VI) electromyography (EMG) evidence of the chronic 
denervation at C7-T1 myotomes; (VII) exclusion of other 
diseases.
MRI studies of cervical spine (C-spine) were conducted 
with a 1.5 Tesla MRI scanner (Intera, Philips, Best, The 
Netherlands) in the neutral position as follows: sagittal T1-
weighted sequences [turbo spin echo, repetition time (TR) 
ms/echo time (TE) ms of 400/10], sagittal T2-weighted 
sequences in all patients (TR/TE 3,500/120); in four 
patients axial T2-weighted sequences (TR/TE 3,000/120) 
cord flattening (CF) was present in 5 patients of 8 (62.5%).
Conclusions: HD is a rare entity and a self-limited condition, but it has to be early differentiated from 
other diseases that may determine myelopathy and amyotrophy to establish a correct therapy and limit arm 
impairment. MRI is very important to confirm the clinical suspect of HD and a standardized MRI protocol 
using axial and sagittal images in both neutral and flexing position is needed, in order to diagnose and follow 
up affected patients.
Keywords: Magnetic resonance imaging (MRI); Hirayama’s disease (HD); spinal cord; atrophy
Submitted Jun 10, 2016. Accepted for publication Jul 24, 2016.
doi: 10.21037/qims.2016.07.08
View this article at: http://dx.doi.org/10.21037/qims.2016.07.08
366 Vitale et al. Italian experience of Hirayama’s disease
© Quantitative Imaging in Medicine and Surgery. All rights reserved. Quant Imaging Med Surg 2016;6(4):364-373qims.amegroups.com
were performed. 
The flexion MRI imaging protocol of cervical spine 
consisted for all patients in: sagittal T2-weighted sequences 
(TR/TE 3,500/120) and axial T2-weighted sequences (TR/
TE 3,750/120). Neck-flexion was obtained positioning a 
head-sponge with an angulation between 25–35 degrees 
(depending on patient conformation and collaboration).
The section thickness was 4mm, for both sagittal and 
axial MR imaging in all sequences in neutral and flexed 
position.
The following diagnostic features were evaluated 
(Table 1): abnormal cervical curvature, localized cervical 
cord atrophy in the lower tract (C4–C7), presence of CF, 
intramedullary signal hyperintensity on T2 weighted 
sequences, anterior shifting of the posterior wall of the 
cervical dural sac (ASD) and presence of flow voids (EFV) 
in the posterior epidural space during flexion.
Cervical curvature was considered normal when the 
vertebral bodies C3 through C6 were anterior to a line 
drawn from C2 through C7. An abnormal, straight or 
kifotic, curvature was defined when part or all of the 
vertebral bodies from C3 to C6 met or crossed the line 
from C2 to C7.
Localized cervical cord atrophy was defined as a decrease 
in cord size in comparison with the normal cord above and 
that below the affected level on sagittal and/or axial images (4).
CF was defined as loss of the normal ovoid spinal 
cord configuration without a narrowed or obliterated 
adjacent subarachnoid space; a pear-shaped spinal cord 
was considered as asymmetric CF and a triangular spinal 
cord was considered as symmetric CF. CF was evaluated on 
sagittal and axial images; if neutral images were not available, 
this was assessed on sagittal and axial flexion images.
Intramedullary hyperintesity was considered on axial 
and/or sagittal T2 images if intramedullary high signal 
intensity was noted without evidence of other causes of cord 
compression. 
Anterior shifting of posterior dural sac (ASD) and 
presence of abnormal epidural flow voids (EFV) were 
evaluated on flexion MRI studies. ASD was defined as 
an abnormal detachment and anterior dislocation of 
the posterior wall of dural sac during neck flexion with 
enlargement of posterior epidural space. EFV, if present, 
was suggestive of engorgement of posterior epidural venous 
plexus.
Results 
Demographics and clinical features (Table 2)
Patients were prevalently males (male/female ratio =3/1) with 
mean age of 17.8 years at the time of clinical presentation. 
All patients were white and two of them were brothers. 
Mutations in the glycyl-tRNA synthetase (GARS) gene were 
excluded in the familial case. 
All patients complained of weakness in hand muscles 
as initial symptoms, associated with hand tremor in three 
of them and abnormal sweating of the hand palm in 
two of them. No sensory deficits and weakness at lower 
limbs were reported by any patients. Distal deep tendon 
reflexes at upper limbs were absent in all patients with the 
absence of the right tricipital reflex in one of them. Deep 
tendon reflexes at lower limbs were normal and no signs 
of pyramidal tract involvement were present. The clinical 
involvement at onset was unilateral in six patients (three 
left-sided and three right-sided) and bilateral asymmetric 
in two of them, with the right side more affected. With 
the progression of the disease, all patients but one 
experienced weakness and wasting of hand muscles and 
forearm bilaterally, but still asymmetric (with the onset 
side more affected than the other one). The duration of the 
progression phase of the disease ranged from eight months 
(1 patient) to three years (3 patients). 
Electrophysiological findings
All patients underwent standard nerve conduction studies 
(NCS), EMG and motor/sensory evoked potentials (MEP/
SEP).
In all patients, NCS and EMG findings were consistent 
with a spinal metameric disorder involving the C7-T1 
myotomes bilaterally (prevalent on the right side in three 
patients and on the left in two). Sensory conduction and 
Table 1 MR signs of HD evaluated on neutral and neck-flexed 
position
MR-sign MR-position
Anterior dural shifting Flexion
Epidural flow-voids Flexion
Cord flattening Neutral or flexion
Localized cord atrophy Neutral
Abnormal cervical curvature Neutral
T2- hyperintensities Neutral
MR, magnetic resonance; HD, Hirayama’s disease.
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electrophysiologic features at lower limbs were normal. 
MEP and SEP were normal and we did not observe the 
disappearance of the spinal potential during the neck flexion 
in any of the patients.
Cervical MRI findings (Table 3)
All patients had loss of the normal cervical lordosis (100%) 
(Figure 1).
Five patients had loss of attachment and anterior dural 
shift on flexion MRI with presence of flow voids from 
venous plexus congestion (62.5%) (Figure 2); three patients 
had no anterior dislocation of the dural sac and no epidural 
vein congestion. 
Two patients showed localized cord atrophy, one at C5–
C6 and the other at C6–C7 level (25%). Three patients had 
T2 intramedullary hyperintensities (37.5%) (Figure 3), in 
both neutral and flexion position.
Table 2 Overview on patient population
Patient 
number
Onset
CI
PPD 
(months)
Clinical features (weakness and atrophy)
Absent TR TremorsAge 
(years)
Side SS
Hands 
intrinsics MM
Fingers 
extensors MM
Biceps/triceps 
brachii MM
1 19 Bilateral
Tremor and hand 
weakness
Yes  
(L > R)
12 No Yes (L>R) No
Distal reflexes 
at upper limbs
Yes  
(bilateral)
2 15 Bilateral
Tremor and hand 
weakness
Yes  
(R > L)
36 Yes (R > L) Yes (R > L) No
Distal reflexes 
at upper limbs
Yes  
(R hand)
3 17 R
Progressive hand 
weakness
Yes 36 Yes (R > L) Yes (R > L) Yes (tricipital)
Distal reflexes 
at upper limbs 
and R tricipital
No
4 18 R
Hyperhidrosis and 
hand weakness
Yes 12 No Yes (R > L) No
Distal reflexes 
at upper limbs
No
5 17 R
Progressive hand 
weakness
Yes 12 Yes Yes No
Distal reflexes 
at upper limbs
No
6 23 L
Tremor and hand 
weakness
Yes 36 Yes Yes No
Distal reflexes 
at upper limbs
Yes  
(L > R)
7 16 L
Hyperhidrosis and 
hand weakness
Yes 24 Yes Yes No
Distal reflexes 
at upper limbs
No
8 18 L
Progressive 
weakness
Yes 8 Yes Yes No
Distal reflexes 
at upper limbs
No
SS, signs and symptoms; CI, contralateral involvement; PPD, progression phase duration; MM, muscles; TR, tendon reflexes, L, left; R, 
right.
Table 3 MR findings of HD in neutral and neck-flexed position in our patients
Patient number ASD EFV CF LCA T2 HT ACC
1 Yes Yes Yes No No Yes
2 No No No  No No Yes
3 Yes Yes Yes Yes Yes Yes
4 Yes Yes Yes Yes Yes Yes
5 No No No No Yes Yes
6 No No No No No Yes
7 Yes Yes Yes No No Yes
8 Yes Yes Yes No No Yes
MR, magnetic resonance; HD, Hirayama’s disease; ASD, anterior shifting of posterior dural sac; EFV, epidural flow-voids; CF, cord 
flattening; LCA, localized cord atrophy; T2 HT, T2 hyperintensities; ACC, abnormal cervical curvature.
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CF was present in 5 patients of 8 (62.5%).
Other findings were: 3 patients presented slight 
intersomatic disc protrusions: 1 patient between C4 and C5, 
2 patients between C6 and C7 and 1 patient at C3–C4 level, 
present in both neutral and flexion position. 
Treatment
Patients received no treatment for their neurological 
deficits. Some of them were proposed to undergo collar 
therapy, but they were not compliant and suspended the 
therapy after few months. One patient underwent surgical 
treatment with duraplasty. The progression of the disease 
ranged from eight months to three years. 
Discussion
HD is a benign, self-limited, motor neuron disease, 
characterized by asymmetric weakness and atrophy of one 
or both distal upper extremities. Its pathogenesis is strongly 
debated. The main hypothesis is that HD is a myelopathy 
related to flexion movements of the neck, during which 
there is a forward displacement of a tight dural sac 
compressing the cervical cord (18). The compression 
would lead to an increased intramedullary pressure 
causing microcirculatory disturbance in the anterior horn. 
Hirayama et al. speculated that disproportionate growth 
between the vertebral column and its canal contents during 
growth spurt, could cause a tight dural sac leading to the 
flexion myelopathy (1). Strenuous exercise of the arms and 
Figure 1 T2-weighted sagittal in (A) normal individual showing 
normal cervical lordosis; (B) patient with HD showing loss of 
cervical lordosis. HD, Hirayama’s disease.
Figure 2 T2-weighted sequence on sagittal (A) and axial (B) 
planes. Posterior detachment and forward shifting of the dural 
sac with presence of epidural flow-voids from posterior venous 
plexus congestion, during neck-flexion (A). Antero-posterior cord 
flattening is evident on the axial plane (B).
Figure 3 T2-weighted sequence on sagittal (A) and axial (B) 
planes. Right-sided intramedullary hyperintensity at the level of 
C5–C6.
A B
BA
A B
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repeated neck flexions, were noted in affected patients and 
speculated as risk factors (5,20). 
Nevertheless some studies showed no substantial clinical 
and radiological modifications with neck flexion and 
contradict this hypothesis (12,17).
Some authors proposed atopy and elevated IgE serum 
levels as participating factors, based on the evidence of 
some cases of atopic myelitis and a higher frequency of 
allergic diseases and hyperIgEaemia in patients with HD; 
some patients had also more severe disabilities (21-24). An 
involvement of intrathecal immune/inflammatory process 
was proposed by Tanaka et al. (25), that revealed intrathecal 
upregulation of IFN-gamma and MIP-1beta in HD 
patients. 
Gamez et al. (26) revealed no relationship between HD 
pathogenesis and SMN1/SMN2 genes, associated with some 
motor neuron diseases.
From a clinical point of view, HD has a stationary 
stage after a progressive phase of the neurological deficits 
interesting the C7, C8 and T1 myotomes of about 1–5 years. 
The disease affects young people, predominantly men, 
in the second to third decades of life and is characterized 
by the insidious onset of predominantly unilateral or 
bilateral asymmetric weakness and atrophy of the distal 
forearm and hand including thenar, hypothenar, interossei 
muscles and wrist flexors and extensors, with sparing of 
the brachioradialis muscle. This topography gives the 
characteristic appearance of “oblique amyotrophy” (1).
The duration of the progressive phase of the disease in 
our population was between eight months and three years 
and the presence of weakness and atrophy of forearm and 
arm was consistent with the literature; in our series, the most 
common symptom at onset was weakness (50%). All our 
patients had the classic pattern of “oblique amyotrophy”.
Other typical clinical features include “cold paresis”, 
worsening of symptoms with cold exposure, and no 
abnormalities of tendons reflexes, sensory disturbance and 
pyramidal signs (14,15,27).
Muscular impairment could be initially unilateral, with 
right upper limb more frequently affected, but secondary 
asymmetric bilateral involvement is possible (28). Rarely, 
symptoms could be bilateral and symmetric (1) with a 
reported prevalence from 3% to 10% (5). In our series, 
unilateral involvement at onset was present in six patients. 
Two patients had bilateral involvement, in one case at onset; 
in both, impairment was asymmetric with right side more 
affected.
Atrophied muscles can show signs of acute or chronic 
denervation at EMG and reduction of amplitude of 
compound muscle action potentials; nevertheless, in 
patients with unilateral amyotrophy, homonymous muscles 
of the unaffected side can show denervation. In about 
25–50% of cases non-atrophic muscles of the affected 
side sometimes can show denervation (i.e., triceps brachii, 
brachioradialis, biceps brachii and deltoid muscles). Motor 
nerve conduction velocities are usually normal (1,29).
Motor evoked potential after transcranial magnetic 
stimulation shows an increased latency and decreased 
amplitude which is temporally aggravated by neck flexion. 
During the progressive phase of the disease, neck flexion 
could lead to a decrease of F-wave persistency; other 
features are increased latency and high amplitude waveform 
suggesting denervation/reinnervation. In patients with 
severe wasting, the F-wave may become unrecordable (27).
Contrariwise, Misra et al. and Ammendola et al. found no 
significant differences between standard and flexed position 
for F-wave parameters, suggesting a different etiology 
for HD than flexion myelopathy (2,12). Hassan et al. and 
Ghosh et al. showed no electromyographic abnormalities of 
C5 and C6 myotomes (27,28).
In our series chronic denervation at EMG of C7, C8 and 
T1 myotomes was evident in all patients; C5 and C6 were 
spared. Electromyographic abnormalities were bilateral, 
but some patients had right (3) or left (2) prevalence, in 
agreement with their symptoms. No sensitive conduction 
abnormalities were found. 
Diagnostic imaging is very important to support clinical 
suspect of HD. Conventional radiographic examinations 
of the cervical spine may show loss of cervical lordosis (27) 
or a hyperflexed cervical motion rate (30). In the 80’s, 
myelography and CT-myelography, in neutral and neck 
flexed position, were used to evaluate patients with 
suspected HD demonstrating atrophy of the lower cervical 
cord and forward displacement of a tightened dural sac (14). 
However, myelography is an invasive investigation that 
needs to retain the contrast medium in the subarachnoid 
space during neck flexion, so it is hard to perform. On axial 
images at CT myelography asymmetric CF could be seen, 
with epidural space appearing as an area of hypodensity 
behind the dura (31).
MRI is the best diagnostic tool in the diagnosis of HD; 
it is a non-invasive modality that can reveal some features 
when performed in neutral and neck-flexion position. MRI 
can confirm clinical diagnosis and exclude other conditions 
responsible for the neurological deficits leading to a correct 
patient management and therapy, limiting arm impairment.
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Forward shifting of the posterior dural sac and 
engorgement of posterior epidural venous plexus are 
considered the characteristic signs of HD in flexion cervical 
MRI (1,15,32).
Some authors (31,33,34) reported the presence of forward 
shifting of the dural sac in all their patients. Nevertheless this 
sign is not always present in HD patients. Zhou et al. and 
Lheman et al. reported a prevalence respectively of 71% and 
76% (10,35). Interestingly, Lai et al. (36) demonstrated the 
presence of anterior shifting of posterior dural sac in 46% of 
healthy subjects, of a lesser degree compared to patients group 
and without evidence of cord compression. Nonetheless, they 
suggested that forward shifting of the posterior dural sac on 
neck flexion can occur as normal variation and its presence 
does not always lead to diagnosis of HD. In our series anterior 
displacement of posterior cervical dural sac was present in five 
of eight patients, a percentage consistent with the literature. 
Hou et al. (37) postulated that neck flexion angle had effects 
on the presence of anterior dural shift, evidence of cervical 
epidural space and flow voids; they suggest a flexion of 25 
degrees at least, 35 degrees as the best choice. 
In patients with HD an engorged epidural venous plexus 
was seen in MRI flexion studies; five of eight patients had this 
sign in our study. These vascular changes were confirmed 
by angiographic and CT-venography exams (11,38,39) and 
a possible additional role had been proposed to concur with 
the arterial ischemia in the pathogenesis of HD. Venous 
engorgement is suspected to be secondary to some co-existing 
mechanisms such as an impaired venous drainage toward the 
jugular veins during neck flexions and an increased flow to 
posterior internal vertebral venous plexus resulting from the 
negative pressure in posterior epidural space as a result of 
anterior shifting of the dura (11,27). Nevertheless, in a case 
report, Patel et al. (40), showed no change in venous epidural 
pressure in the flexed position suggesting a passive dilatation 
of the epidural plexus. Recently, Gupta et al. utilized the 
3D-CISS sequence to enhance the presence of the epidural 
flow voids, because it allows better cerebrospinal fluid to 
tissue contrast (41). On flexion sagittal T1-weighted images, 
posterior detachment with forward shifting of the dural 
sac allows to observe a widened posterior epidural space 
appearing as a low intensity “crescent shaped epidural mass” 
with flow voids and uniform enhancement of this crescentic 
area on post-contrast images (4,6,31,41).
Among the other MRI features, asymmetric CF, localized 
lower cervical cord atrophy and loss of posterior dural 
attachment have a reported accuracy of about 80% in HD 
diagnosis (27,42).
Chen et al. (42) proposed loss of attachment with 
the subjacent lamina (LOA) as the most reliable sign on 
neutral position cervical MRI; they reported a prevalence 
in their series of 93% among the patients group. Because 
of the rarity of HD in Europe and Italy we did not use 
standardized MRI protocols and we could not evaluate LOA 
because of the lack of axial T2-weighted images in neutral 
position for all patients. So, despite of its rarity, we want to 
underline the importance of suspecting Hirayama’s disease 
and establishing standardized MRI protocols to research 
diagnostic features on both axial and neck-flexed position. 
We suggest that every patient with a clinical suspect of 
HD would undergo the following MR C-spine protocol 
including at least:
Sagittal T1-weighted and T2-weighted sequences and 
axial T2 or T2*-weighted sequence in neutral position; 
sagittal T2-weighted sequences and axial T2 or T2*-
weighted sequence in a neck- flexion of 35 degrees as best 
choice, at least 25 degrees (being the axial T2 or T2*-
weighted sequence during flexion perpendicular to the 
spinal cord). Sagittal T1-weighted sequences in neck-flexion 
before and after gadolinium intravenous administration 
could be added.
CF has a various prevalence in different case series. Yin et al., 
Hassan et al. and Raval et al. (6,27,31) reported a 100% of 
prevalence while Lehman et al. (10) and Yang et al. (32) 
found it respectively in 48% and 43%. Finsterer et al. (9) 
executed MRI studies in the neutral position and reported 
asymmetric CF only in one patient of seven. In our series, 
CF was present in five patients of eight (62.5%).
Localized cervical cord atrophy was reported by Hirayama 
and Tokumaru in about 50% of cases (14). Controversal 
results are present in literature. Sonwalkar et al. and Raval 
et al. (4,31) depicted cord atrophy in 100% of their patients, 
Hassan et al. in 82% of cases. Chen et al. demonstrated 
localized cervical cord atrophy only in their patients group (42). 
Among our patients, only two presented cervical cord 
atrophy, similar to results of Ghosh et al. that described it in 
33% of cases (28).
Contrariwise to other studies, Boelmans et al. executed 
neutral position MRI in eight patients and no one of them 
had CF or localized cord atrophy. Diffusion tensor imaging 
(DTI) evaluation showed no alteration of the cortico-
spinal tract confirming that HD is a primary spinal motor 
neuron disease (43). Recently, attention was pointed on the 
presence of a localized cord atrophy as a “sand-watch”—like 
pattern on sagittal images as a sign of disease (41,44).
All our patients had loss of normal cervical lordosis. In 
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agreement with our finding were the studies of Hassan 
et al. and Raval et al. that depicted loss of cervical curvature 
in 91% and 100% of their patients (27,31). Chen et al. in 
their series founded a statistically significant difference 
between healthy and patients group, with prevalence of 
this sign in the latter. Loss of cervical lordosis is thought to 
be in relationship with the presence of a tight dural sac in 
patients with HD (42). 
Two of our patients (25%) showed T2 hyperintensities 
of the spinal cord respectively at C5–C6 and C6–C7 levels. 
High signal alterations on T2 weighted images without 
cord compression are described in the literature, but this 
finding is inconstant, presenting in about one third or less 
of the patients (10,27,34,42).
Syringomyelia, amyotrophic lateral sclerosis, cervical 
spondilosis associated with myelopathy, spinal cord tumor 
and traumatic myelopathy, may cause localized amyotrophy 
of the distal arm, and should be differentiated from HD 
by imaging modalities. In our familial case we looked for 
mutations in GARS to rule out distal spinal muscular motor 
atrophy type V (45).
Collar therapy or surgical intervention had been 
proposed as treatment for HD. Cervical collar is used 
to avoid neck movements and to prevent progressive 
muscular weakness at early stage of the disease with good 
response; its application for three to four years has been 
advocated (1,28,46). Surgical treatment with cervical spinal 
fusion and duraplasty had encouraging results in selected 
patients. Some authors report better outcomes in patients 
treated surgically than those treated conservatively (47,48). 
Particularly in patients that do not improve with collar 
therapy a surgical intervention could be beneficial, because 
it gives a permanent stable fixation with a shorter period of 
immobilization (27,49). Arrese et al. (50) executed in a case 
duraplasty without spinal fusion to avoid the spinal cord 
compression without limiting cervical motion; recently also 
Ito et al. (51) treated successfully six patients with duraplasty 
without spinal fusion, improving neurological deficits and 
supporting tight dural canal theory for HD. To all our 
patients it was suggested to avoid sports or situations that 
might induce neck trauma. Some of them were proposed 
to undergo collar therapy, but they were not compliant 
and suspended the therapy after few months. One patient 
underwent surgical treatment with duraplasty.
Conclusions
HD is a rare entity, more frequent in Japan and Asian 
countries,  characterized by unilateral or bilateral 
asymmetric weakness and atrophy of the hands and 
forearms, particularly in men. It’s a self-limited pathology, 
but it has to be differentiated early from other diseases that 
could determinate myelopathy and amyotrophy to establish 
a correct therapy and limit arms impairment. 
MRI is very important to confirm clinical suspect of HD 
and a standardized MRI protocol using axial and sagittal 
images in both neutral and flexed position is needed in 
order to make diagnosis and to follow up affected patients.
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